Friday, August 30, 2013

Consequences Of Maxing Out Your Credit Card

Hot Value Stocks To Own For 2014

There are over 600 million credit cards held by U.S. consumers and the average credit card debt per household averages about $16,000 according to the Federal Reserve's February 2012 report on consumer debt. Just because your card company offers you a $5,000 limit, doesn't mean that you have to come close or exceed this amount. Some of this debt can be a reflection of carrying a high credit card balance or maxing out on credit card purchases. With the average credit card holder owning 3.5 cards, it's important to manage and keep track of purchases made with your card, so you don't go over your credit card limit or cap.

Consequences
If for some reason you are nearing your credit card limit or if you go over your limit, there are dire consequences. You should be aware and prepared for the penalties and fees that will incur. When you max out on your card, you owe a debt to the credit card company and you're expected to pay it.

There are various reasons why you shouldn't max out your credit card. First off, you won't be able to use your card at any time once you push your card to the limit.

You will need to pay off a portion of the balance in order for you to use the card again. Some companies will close or put a freeze on the account all together, requiring you to pay the entire amount in full in order to use the card again. You can bet on the fact that your credit score will be affected and will drop. The majority of you credit score is based on how much "available" credit you use.

Thirty percent of an individual's FICO score is affected by what happens on the card. If you had good credit before you applied for the card, that will surely change the course of things, when you max out your card.

If you try to refinance a mortgage loan, apply for educational loans or attain additional credit, the maxed out card will show up on your credit report which look bad on your part and can determine if you are a risk or not.

At the lender's discretion, they can charge a default rate if you max out. These rates can vary depending on the company and can rise as high as 30% or more depending on the balance, which could spell disaster for your repayment plans.

Depending on your credit cap, if you're paying the minimum balance, the repayment can take up to a few years. The balance can include finance and interest charges that accrue along with over-limit fees which can balloon your balance. Don't miss any payments or pay late under any circumstances. This may increase your minimum payment amount and the lender can raise your interest rates which will affect your overall credit score.

What you can do
You can always choose to pay the balance in full; again this is depending on how much the balance is. The best way to prevent going over your credit card limit is to stop the spending and create a budget in advance and establish where and when you want to spend your money. You can also sign up for email or text alerts to tell you when you're about to go over your limit.

Kaia Zawadi is a professional freelance journalist/writer/editor. She regularly writes stories about banking and personal finance for MyBankTracker.com

Thursday, August 29, 2013

Westamerica Remains Underperform - Analyst Blog

Hot Heal Care Stocks For 2014

On Jul 9, 2013, we reiterated our long-term recommendation on Westamerica Bancorp. (WABC) at Underperform. Our decision rests on Westamerica's mounting expenses.

Why Underperform?

Westamerica's net interest margin (NIM) has been declining over the last several quarters due to the challenging economic environment. Moreover, sluggish economic recovery and the Federal Reserve's decision to keep short-term interest rates low through mid-2015 are expected to keep NIM under pressure going forward.

Further, Westamerica's interest earnings assets have remained a matter of concern due to the weak interest rates and low investment returns amid a sluggish economic recovery.

Also, Westamerica has been continuously experiencing pressure on its credit quality, which is anticipated to increase in the upcoming quarters due to the prevailing weak macroeconomic environment. Further, Westamerica's securities portfolio has historically remained higher than its peers, which is expected to adversely affect the quality of earnings.

For Westamerica, the Zacks Consensus Estimate for 2013 has gone down 1.9% to $2.58 per share over the last 90 days. Likewise, the Zacks Consensus Estimate for 2014 has declined 2.3% to $2.56 per share over the same time frame. With the Zacks Consensus Estimates for both 2013 and 2014 going down, Westamerica currently carries a Zacks Rank #3 (Hold).

Westamerica is scheduled to announce its second-quarter results on Jul 16. The Zacks Consensus Estimate for the quarter is pegged at 64 cents per share.

Other Stocks Worth Considering

Some stocks that are performing well include Central Pacific Financial Corp. (CPF), Preferred Bank (PFBC) and TriCo Bancshares (TCBK). All these carry a Zacks Rank #1 (Strong Buy).

Wednesday, August 28, 2013

Encana Upgraded to Outperform - Analyst Blog

Top 10 Medical Companies To Buy Right Now

On Jul 09, 2013, we upgraded Canadian natural gas producer Encana Corp. (ECA) to Outperform from Neutral.

Why the Upgrade?

Encana has one of the largest natural gas resource portfolios in North America, which provides a diverse/high quality inventory of reserves. We see a solid long-term future for the company as demand for natural gas soars, spurred by its cost effectiveness and abundant supply in North America. A prudent asset disposition strategy and an ever-increasing share of liquids production are other positives in the Encana story.

Detailed Analysis

Calgary, Alberta-based Encana – one of North America's largest producers of natural gas along with the likes of Exxon Mobil Corp. (XOM) and Chesapeake Energy Corp. (CHK) – was an early mover in areas like the Horn River Basin in northeastern British Columbia and the Haynesville shale in Texas and Louisiana. It has amassed formidable land positions in both of those emerging regions and others. The company hopes to take advantage of the lower-than-average reserve decline rates and low-risk drilling opportunities that have characterized unconventional resource development across the industry in recent years.

We remain highly optimistic regarding the collaboration of Encana and Mitsubishi in developing the Cutbank Ridge, which is one of the most fertile and low-cost resource rich acreages in North America. With large proved undeveloped natural gas reserve, the region is expected to have the capacity of delivering long-term, affordable energy supplies to domestic and overseas markets.

We appreciate Encana's strategy of disposing assets that do not fit into its long-term growth plan. The company's divesture program includes the disposition of high cost yet low profit generating assets and a focus on asset base expansion that would render high returns. The ! net proceeds received from these property sales (more than $1.5 billion in 2011 and over $4 billion in 2012) also render a strong financial flexibility to the company.

Other Stocks That Warrant a Look

In addition to Encana, one can look at W&T Offshore Inc. (WTI) as a good buying opportunity. This North American upstream energy operator – sporting a Zacks Rank #1 (Strong Buy) – have solid secular growth stories with potential to rise significantly from current levels.


Monday, August 26, 2013

Where Will Activision Blizzard Go Next?

With shares of Activision Blizzard (NASDAQ:ATVI) trading around $17, is ATVI an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let's analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Activision Blizzard is a worldwide publisher of online, personal computer, console, handheld, and mobile interactive entertainment products. The company operates in three segments: Activision Publishing Inc., Blizzard Entertainment Inc., and Activision Blizzard Distribution. Through its segments, it publishes interactive entertainment software products and downloadable content. It also creates real-time strategy, role-playing PC games, and online subscription-based games in the multi-player online role-playing category, as well as distributes interactive entertainment software and hardware products. Online gaming is becoming increasingly popular — as a company at the root of this growing industry, Activision Blizzard stands to see significant gains.

Activision Blizzard is buying itself back from French media company Vivendi, repurchasing 429 million shares for $5.83 billion. Activision Blizzard is responsible for popular video game titles, like Call of Duty and World of Warcraft. The buyout comes in advance of the release of Sony's (NYSE:SNE) PlayStation 4 and Microsoft's (NASDAQ:MSFT) Xbox One.

T = Technicals on the Stock Chart are Strong

Activision Blizzard stock has seen a consistent uptrend over the last several months. The stock is now trading at highs for the year. Analyzing the price trend and its strength can be done using key simple moving averages.

What are the key moving averages? They are the 50-day (pink), 100-day (blue), and 200-day (yellow) simple moving averages. As seen in the daily price chart below, Activision Blizzard is trading above its rising key averages, which signals neutral to bullish price action in the near-term.

ATVI

(Source: Thinkorswim)

Taking a look at the implied volatility (red) and implied volatility skew levels of Activision Blizzard options may help determine if investors are bullish, neutral, or bearish.

Implied Volatility (IV)

30-Day IV Percentile

90-Day IV Percentile

Activision Blizzard Options

33.66%

0%

0%

What does this mean? This means that investors or traders are buying a very small amount of call and put options contracts, compared to the last 30 and 90 trading days.

Put IV Skew

Call IV Skew

August Options

Flat

Average

September Options

Flat

Average

As of today, there is an average demand from call buyers or sellers and low demand by put buyers or high demand by put sellers, all neutral to bullish over the next two months. To summarize, investors are buying a very small amount of call and put option contracts, and are leaning neutral to bullish over the next two months.

On the next page, let’s take a look at the earnings and revenue growth rates, and what this means for Activision Blizzard’s stock.

E = Earnings Are Increasing Quarter-Over-Quarter

Rising stock prices are often strongly correlated with rising earnings and revenue growth rates. In addition, the last four quarterly earnings announcement reactions can help gauge investor sentiment on Activision Blizzard’s stock. What do the last four quarterly earnings and revenue growth (Y-O-Y) figures for Activision Blizzard look like, and more importantly, how did the markets like these numbers?

2013 Q1

2012 Q4

2012 Q3

2012 Q2

Earnings Growth (Y-O-Y)

21.21%

300.00%

53.85%

-44.83%

Revenue Growth (Y-O-Y)

12.97%

25.66%

11.54%

-6.20%

Earnings Reaction

-5.70%

11.19%

-1.16%

-5.52%

Activision Blizzard has seen rising earnings and revenue figures over the last four quarters. From these numbers, it seems the markets have expected more from Activision Blizzard’s recent earnings announcements.

P = Average Relative Performance Versus Peers and Sector

How has Activision Blizzard stock done relative to its peers, Electronic Arts (NASDAQ:EA), Sony (NYSE:SNE), Zynga (NASDAQ:ZNGA), and the overall sector?

Activision Blizzard

Electronic Arts

Sony

Zynga

Sector

Year-to-Date Return

62.71%

76.52%

92.41%

23.73%

42.71%

Activision Blizzard has been an average relative performer, year-to-date.

Conclusion

Activision Blizzard provides online entertainment products and services to a growing group of people worldwide. The company is now attempting to repurchase itself from its French owner. The stock has been on a strong surge higher in recent months, and is now trading near highs for the year. Over the last four quarters, it seems investors in the company have expected more, but earnings and revenue figures have been rising. Relative to its peers and sector, Activision Blizzard has been an average year-to-date performer. Look for Activision Blizzard to OUTPERFORM.

Sunday, August 25, 2013

Diversification: Too Much of a Good Thing, Can Be a Great Thing



Berkshire Annual Shareholder Letter:

"That's assured by the general volatility of the stock market, by the concentration of our equity holdings in just a few companies, and by certain business decisions we have made, most especially our move to commit large resources to super-catastrophe insurance."

We not only accept this volatility but welcome it: "A tolerance for short-term swings improves our long-term prospects. In baseball lingo, our performance yardstick is slugging percentage, not batting average."

Warren Buffett once said, "Diversification is protection against ignorance. It makes little sense if you know what you are doing."

Humans love diversification and this can be attributed to the diversification bias, as we do not like to lose an option even if the option was a bad one. Sometimes less is more and quality is better than quantity. Risk is not adequately reduced by further diversifying your stock market holdings as they are all susceptible to the same systematic risks (depending on credit class). Diversification would not have been able to entirely save you from October 2007 to March 2009 (during the credit crisis) the S&P500 declined 57%. While many companies did close their doors for good, many survived and have thrived in the new environment.

Extreme bargains do not come around everyday and it is best to go for the jugular when the opportunities present themselves, focusing your holdings in the cream of the crop.

Of course, if you insist on diversifying and are happy with average market returns, continue the 30-to-50 basket holding approach. But why not buy a low cost index fund and save yourself the headache of choosing winners and discarding losers? The systematic risk of a portfolio cannot be diversified away no matter how many holdings you decide to have. Although diversification can reduce the risk of individual securities from business failure or traumatic events and does help reduce risk initially, the average portfo! lio returns began to diminish after five holdings as depicted in "The Effect of Diversification on Risk" in the Financial Analyst Journal Vol. 27, No.6 (Nov-Dec) 1971 by W. H. Wagner and S. C. Lau.

[ Enlarge Image ]
As shown above, the standard deviation is not affected greatly after five to 10 holdings and after 50 holdings, there is virtually no effect.

Ben Graham was an advocate of diversification using qualitative analysis as a guide to buy under valued securities selling under book value or "net-nets." Over time, most holdings would recover, although a few would perish, but on average a reasonable return would be made for the owner of the basket of value. Buffett has been quoted saying, "The irony is that while Graham was a qualitative investor, he made more money investing in Geico than all other investments his firm made, combined."

Friday, August 23, 2013

Commodity-ETF Assets Fell $49B in Q2: Report

A report issued Friday by ETF Securities says that record outflows tied to a boost in interest rates, decline in gold prices and related factors led to large outflows from commodity-focused exchange-traded products from March to June.

As a result, assets in commodity focused ETPs dropped $49 billion during the second quarter to hit $127 billion, the lowest level since Q2 2010.

On the upside, the report’s authors note, gold ETP outflows–which peaked in April–moderated in May and June. “The moderation may indicate that the worst of the gold ETP selling is now behind us,” they stated.

For investors looking for a bright spot, ETF Securities points to platinum, which had $712 million of inflows in the second quarter due to concerns over growing supplies.

“The outlook for most commodity flows and prices will likely turn on perceptions of whether the recent liquidity squeeze and growth scare in China is temporary or the start of a larger trend,” explained Michael Langerup, Edith Southammakosane and their colleagues. “Gold and silver will likely remain beholden to views on the Fed’s intentions and the direction of real interest rates. On both counts we believe investor reactions have been overdone.”

Gold Hit

Gold ETPs had close to $19 billion of net outflows in Q2, the largest quarterly outflows since the first gold ETP was created in 2003.

Gold ETP assets declined by $48.9 billion during the period.

“More than 60% of the fall in gold ETP AUM was driven by gold prices dropping by over a fifth,” the report stated, as real interest rates rose, the markets adjusted to expectations of a drop in Fed bond buying and the U.S. dollar strengthened.

Other Metals

ETPs focused on platinum had $712 million of net inflows in Q2. Supplied remained tight, and there were rising concerns about future supplies in South Africa, where labor disputes and power shortages have been a concern.

Palladium saw strong inflows in April and May, which reversed in June when China’s growth came into focus

Copper ETPs had $67 million of inflows in May and June tie to fears that accidents at mines in Indonesia and the United States would hurt global supply. Concerns over slowing growth in China contributed to outflows in April of $137 million

Zinc drew $13 million of net inflows during the quarter.

Agriculture, Oil

Agriculture ETPs had net outflows of $108 million in Q2, which reversed most of the Q1 inflows. The outflows appeared to be related to rising supply expectations for grains and soybeans after record planting.

“As we saw last year, severe drought conditions can quickly change these expectations, and flows into these products are likely to be sensitive to weather conditions over the course of the summer,” ETF Securities noted.

10 Best Blue Chip Stocks To Invest In Right Now

Tightening West Texas Intermediate oil-supply conditions led to a slowdown in outflows from oil ETPs to $170 million in Q2 vs. outflows of $848 million Q1. There were signs that U.S. oil inventories peaked early in the most-recent quarter, which provided a tailwind for prices.

Conclusions

Gold prices were the main factor in the Q2 drop in commodity ETP assets, as investors sold into the price declines and exacerbated outflows.

Concerns over possibly austerity moves in China, along with shifts in U.S. Fed policy, dominated investor thinking.

“In our view, both the fall in gold price and investor selling of gold ETPs is overdone,” the ETF Securities experts stated. “We believe the recent sharp rise in real interest rates has been excessive given the macro environment, and any unwind should help support the gold price and gold ETP flows.”

If bumps in China’s growth story turn out to be temporary, for instance, prices for platinum, palladium and copper could improve along with inflows.

“The current soft patch in agricultural ETP demand could turn very quickly if drought conditions we saw last year in the US return,” the report concluded. “Moreover, agriculture has a relatively low correlation with the business cycle, which may attract contrarian investors looking for uncorrelated assets.”

Sunday, August 18, 2013

Roche Seeks Label Expansion for Test - Analyst Blog

Top Canadian Companies To Own In Right Now

Roche (RHHBY) recently announced that it has submitted a Premarket Approval (PMA) supplement to the US Food and Drug Administration (FDA) for its cobas Human Papillomavirus (HPV) test.

The company is looking to get the test approved for an additional indication.

Roche is seeking an additional cervical cancer primary screening indication for the test.

Approval for the above mentioned indication will enable the use of the cobas HPV test as a first-line test to screen patients for cervical cancer rather than using Pap cytology.

The PMA was filed based on a new three-year follow-up data from the ATHENA study wherein more than 47,000 women were screened for cervical disease with Pap and HPV tests in the US.

The FDA had approved the cobas HPV test in Apr 2011 for the screening of patients 21 years of age and above with abnormal Pap test results and to co-test with Pap in women between 30 and 65 years of age to assess the presence or absence of high-risk HPV genotypes.

We note that Roche provides tests for the detection of HPV, chlamydia and gonorrhea (CT/NG) along with genotyping of HPV to identify high-risk HPV types which are known to be associated with progression to cervical cancer.

Apart from providing therapeutic products and services for diverse medical needs, Roche continues to focus on innovative diagnostic solutions for the early detection and treatment of diseases.

Roche launched 55 major products in key markets in its diagnostics division in 2012. The product launches included advances in lab automation, patient testing and diabetes management coupled with expansion of the existing test menus.

We note that Roche's diagnostics segment accounted for 22.5% of total sales in 2012 with a 4% increase in sales.

We are encouraged by Roche's efforts to broaden its diagnostics portfoli! o. Roche invested CHF 900 million in 2012 to develop its technologies and products.

Roche plans to launch 13 different solutions in 2013, out of which 5 were launched in the first quarter of 2013.

We note that Abbott Labs' (ABT) RealTime High Risk HPV molecular diagnostic test also enables detection of HPV which is the prime cause of cervical cancer.

Roche currently carries a Zacks Rank #4 (Sell). Right now, Valeant Pharmaceuticals (VRX) and Santarus, Inc. (SNTS) look attractive, each with a Zacks Rank #1 (Strong Buy).

Saturday, August 17, 2013

7 Articles ETF Investors Must Read: 8/2

Wall Street was in for yet another round of lackluster trading and mixed earnings and economic reports this week, while investors braced themselves for Federal Reserve's policy-setting committee statement on Wednesday. In economic news, pending home sales declined 0.4% in June, while the S&P/Case-Shiller 20-City home-price index rose 12.2% in May on the year versus the 12.4% uptick analysts were expecting. The Conference Board reported its consumer-confidence index falling to 80.3 in July, slightly below analyst expectations of 81.5. Meanwhile, U.S. GDP came in above expectations, rising 1.7% in the second quarter, though the overall pace of growth remained lackluster . 

Below, we highlight seven insightful articles circulating around the financial space this week:

Is the market headed for a correction? Not quite yet, but soon (Pretzel Logic's Market Charts and Analysis)12 must read quotes from Gerald Loeb (StockTwits 50)Russian potash firm breaks up one of the world's largest marketing cartels (agrimoney.com)Is now the time to buy municipal bonds? (Financial Sense)Europe's economy is still worse off than it was in 2009 (Quartz)A closer look at PE ratios around the globe (Musings on Markets)Commodities are breaking down (TheArmoTrader)Follow me on Twitter @DPylypczak.

Disclosure: No positions at time of writing.



Friday, August 16, 2013

JPMorgan to Expand in Iraq - Analyst Blog

In an attempt to capture the global market, JPMorgan Chase & Co. (JPM) plans to expand its business in Iraq – OPEC's (Organization of the Petroleum Exporting Countries) second largest country after Saudi Arabia. JPMorgan entered into a one-year definitive agreement with Trade Bank of Iraq to finance the latter's import of goods and services.

With this, JPMorgan would be in a position to assist Trade Bank of Iraq in opening more letters of credit in the country. Previously, JPMorgan had helped the bank to aid imports required for the country's post-war restructuring.

Iraq is the world's fifth-largest proven oil reserve. Nevertheless, after being battered by crippling wars and neglect for decades, Iraq gradually initiated the process of improving its infrastructure and energy industry. As per Bloomberg, Iraq produced nearly 3.2 million barrels a day of crude oil in Jun 2013 and has further targeted to produce over 3.5 million barrels a day by the end of 2013.

Moreover, the government has increased its spending by 18% to $118 billion in 2013. Additionally, according to International Monetary Fund (IMF), the annual economic growth rate of Iraq is expected to be 9%. Moreover, the increase in Iraq's oil exports and a fall in the prime lending rate from 17% to 6% are a major boost to its expansion plans.

Previously, till 2003, foreign banks were prohibited from trading in Iraq. However, following the expulsion of the Saddam Hussein government in 2003, international banks were permitted to operate in Iraq. As per the central bank's website, currently, 15 international banks have their operations in Iraq, which includes majors like Citigroup, Inc. (C), Standard Chartered PLC (SCBFF) and HSBC Holdings plc (HBC).

Citigroup plans to benefit from the $1 trillion estimated infrastructure spending by the government of Iraq by opening representative offices and branches in Baghdad as well as in the cities of Basra and Erbil. Citigroup also plans to finance a p! ipeline to export Iraqi oil and natural gas through Jordan.

Alongside, Standard Chartered is planning to expand its transaction banking business in Iraq by opening branches in Baghdad and Erbil in 2013 and Basra in 2014.

JPMorgan currently carries a Zacks Rank #2 (Buy).


Thursday, August 15, 2013

Understanding an Industry - Is Simple Better Than Familiar?

Top 5 Penny Stocks To Buy For 2014

Someone who reads my articles sent me this email:

Geoff,

I am a senior in college and I am in the process of interviewing for full-time positions in asset management/equity research. I have a "super week" on campus… where I will have a number of important interviews, and I would like to be able to tell the interviewer, 'I know a lot about x industry.' I am familiar with many industries, but I wouldn't say that I have a deep understanding of any one in particular. Can you recommend an industry that I could sit down and study for the next month and develop a deep enough understanding to tell an interviewer 'I know a lot about this industry'?

I know a lot about oil and gas compared to what I know about other industries, but O&G is such a deep industry that I would feel much more confident trying to master a simpler industry for interviewing purposes.

Thank you for your advice.

- Ted

Honestly, I would go with your instincts. With what you are already interested in. If you know a lot about oil and gas, I would study oil and gas. The most important requirement for understanding anything is your interest in it. Often, it's not enough to "need" to know something. You have to "want" to know it.

My focus is almost exclusively on industries where customer behavior is easy to understand. Where once you have a good idea of how the customer sees the product, how they search for alternatives, etc. you have a good understanding of the business. To me, the simplest industries are industries in which costs are less important to the company because they are less important to the customer. Usually, I am focused on industries where the purchase decision does not involve a very large amount of money relative to the customer's total purchases.

So, I think of simple industries as food, entertainment, etc. And anything where logistics provide a ! competitive advantage. I mentioned a company I own shares of – George Risk Industries (RSKIA) – before. Its advantage is the ability to deliver a cheap product on time. They can't produce the product for less than the competition. If the purchase price was huge relative to what the end customer was purchasing as part of the same activity (the end customer is construction in this case) price competition would be important. Instead, delivery is important.

This is similar to Mid-Continent Tab Card Company. Warren Buffett invested in Mid-Continent Tab Card Company back in his partnership days. Another example of a company that competes on delivery is ADDvantage Technologies (AEY). It's going through some changes now – due to a new (adverse) agreement with Cisco (CSCO). But, historically, it competed on delivery alone. By having products in stock and ready to ship – their motto is "on hand on demand" – ADDvantage could compete with original equipment manufacturers even though those manufacturers could sell the same product (in large numbers and slow delivery times) for much less.

That's my biggest concern with whether an industry is easy to understand or not. If a competitor offers to sell its product for 5% less than you charge, how do you respond? Do you have to respond? Can you ignore price competition like that?

Now, there are obviously industries where price competition is critical and yet the business is easy to understand. Groceries, auto insurance, etc. Even the deposit gathering aspect of some banks is very simple and easy to understand.

The lending part… not so much.

My concern is a durable competitive advantage. Something that I can recognize. I have to be able to understand it. In some sense, to actually imagine it. There are many companies with competitive advantages that are just too esoteric for me to understand. I'd probably recognize them if I worked in that industry day after day. You notice things when you're close enough to see them! illustra! ted every day in a million different anecdotes. Reading about an industry from afar is much harder to do. So the competitive advantage has to be pretty plain and simple. Or I won't see it when I read it. But that's competitive advantages. And I'm not sure competitive advantages are the topic of greatest interest to the folks you'll be interviewing with.

I know that when it comes to what stocks people are most likely to make money on – it often comes down to familiarity. Are you willing to study the company? And then are you willing to trust your judgment when the stock price moves against you – as it almost certainly will – at some critical moment in your holding period. That's how it seems to work with stocks. Picking the right stock is not enough. You have to be able to hold it too.

I know you didn't ask about buying stocks. You asked about a job interview.

But the topic you'll sound best talking about is the topic you're most interested in.

Really, you should go with what you are passionate about. What you are curious about. If you are interested in an industry and apply yourself to understanding it, you'll do fine. I would recommend coming up with a list of public companies in the industry you want to study. Print out the 10-K, 10-Q, and 14A for each. You can get them at EDGAR. Have a pen in hand. Take notes. Compare the companies.

Many of the most important aspects of every company – and the industry itself – will be obvious just from these reports. They are most useful because they are essentially primary sources. A lot of the information you will read about a company or industry has already been shaped by some other analyst (or reporter's) opinion. SEC reports are less likely to cause you to embrace the conventional wisdom where it is wrong.

One thing I would strongly suggest is to avoid reading resources prepared with investors in mind. When doing stock research, you should either use rather dry and formulaic information dumps l! ike the 1! 0-K, 10-Q, and 14A or you should read documents that were specifically created for non-investors. Depending on the industry, there is sometimes a lot of information that was created by or for academics, regulators, customers, industry participants, and general interest audiences. Some of this stuff can be very useful if you make connections with what you find in other reports. Some folks will listen to industry gossip. Others will read the SEC reports. Far fewer will bother to connect the two.

If you can talk to anyone in the industry – whatever their role – I would encourage that. This is easy to do if you gather information on their company, industry, or function ahead of time. If you demonstrate you already know something about the topic and are interested in it all you have to do is let them talk. People love to talk about themselves. And actually talking to folks in the industry can help in a few ways. The most useful is in terms of human behavior. People can often reveal why prejudices and biases exist in certain decisions made in their industry. They can help you understand the human element.

Warren Buffett mentioned doing this before his recent investment in IBM (IBM). Basically, he wanted to know why people would be likely to prefer IBM to competitors and why they stay with IBM. In his CNBC interview, Buffet seems to say there is a certain tendency to bet on the known quantity when it comes to IT providers. He especially mentions this in regard to foreign companies. It was interesting to see Buffett mention doing this kind of scuttlebutt with IBM – because in past interviews he's said that while he used to do all the Phil Fisher scuttlebutt – he'd gotten to the point (by the 1990s and 2000s) where he kept Phil Fisher's principles in mind but he could basically make a decision just from reading public reports.

Talk to Geoff About Understanding an Industry geoff@gurufocus.com

Saturday, August 10, 2013

Will Halliburton See Rising Prices?

With shares of Halliburton (NYSE:HAL) trading around $46, is HAL an OUTPERFORM, WAIT AND SEE, or STAY AWAY? Let's analyze the stock with the relevant sections of our CHEAT SHEET investing framework:

T = Trends for a Stock’s Movement

Halliburton provides a range of services and products for the exploration, development, and production of oil and natural gas. The company operates in two segments: Completion and Production, and Drilling and Evaluation. The Completion and Production segment offers production enhancement services, including stimulation and sand control services, as well as cementing services comprising the bonding of wells, well casing, and casing equipment. The Drilling and Evaluation segment offers drill bits and services, as well as coring equipment and services. It also offers wireline and perforating services, testing services comprising acquisition, and analysis of reservoir information and optimization solutions.

On Monday morning, Halliburton delivered earnings and revenue figures that beat Wall Street's expectations. Not long ago, the company has agreed to plead guilty to destroying evidence related to the 2010 Deepwater Horizon spill on the Gulf Coast, according to the United States Department of Justice. Despite these struggles, consumers and business demand for energy continues to rise, companies like Halliburton are well-positioned to provide products and services well into the future.

T = Technicals on the Stock Chart are Strong

Halliburton stock has rising steady over the last several months. The stock is now trading near highs for the year, and seems poised to continue this path. Analyzing the price trend and its strength can be done using key simple moving averages.

What are the key moving averages? They are the 50-day (pink), 100-day (blue), and 200-day (yellow) simple moving averages. As seen in the daily price chart below, Halliburton is trading above its rising key averages, which signals neutral to bullish price action in the near-term.

HAL

(Source: Thinkorswim)

Taking a look at the implied volatility (red) and implied volatility skew levels of Halliburton options may help determine if investors are bullish, neutral, or bearish.

Implied Volatility (IV)

30-Day IV Percentile

90-Day IV Percentile

Halliburton Options

24.91%

3%

0%

What does this mean? This means that investors or traders are buying a very minimal amount of call and put options contracts, compared to the last 30 and 90 trading days.

Put IV Skew

Call IV Skew

August Options

Flat

Average

September Options

Flat

Average

As of today, there is average demand from call buyers or sellers, and low demand by put buyers or high demand by put sellers, all neutral to bullish over the next two months. To summarize, investors are buying a very minimal amount of call and put option contracts, and are leaning neutral to bullish over the next two months.

On the next page, let’s take a look at the earnings and revenue growth rates, and what that means for Halliburton’s stock.

E = Earnings Are Mixed Quarter-Over-Quarter

Rising stock prices are often strongly correlated with rising earnings and revenue growth rates. In addition, the last four quarterly earnings announcement reactions can help gauge investor sentiment on Halliburton’s stock. What do the last four quarterly earnings and revenue growth (Y-O-Y) figures for Halliburton look like, and more importantly, how did the markets like these numbers?

2013 Q2

2013 Q1

2012 Q4

2012 Q3

Earnings Growth (Y-O-Y)

-8.75%

24.72%

-26.87%

-12.16%

Revenue Growth (Y-O-Y)

1.15%

1.54%

3.20%

8.60%

Earnings Reaction

-1.64%

5.58%

5.05%

3.15%

Halliburton has seen mixed earnings and rising revenue figures over the last four quarters. From these numbers, the markets have been mostly pleased with Halliburton’s recent earnings announcements.

P = Excellent Relative Performance Versus Peers and Sector

How has Halliburton stock done relative to its peers, Schlumberger (NYSE:SLB), Apache (NYSE:APA), Baker Hughes (NYSE:BHI), and the overall sector?

Halliburton

Schlumberger

Apache

Baker Hughes

Sector

Year-to-Date Return

32.80%

17.55%

4.83%

16.78%

14.22%

Halliburton has been a relative performance leader, year-to-date.

Conclusion

Halliburton provides essential oil and gas products and services worldwide. The company has been in the news recently, owing to the company’s latest earnings report, as well as a lawsuit involving the 2010 Deepwater Horizon spill. The stock has been steadily rising, and is now trading near highs for the year. Over the last four quarters, investors in the company have mostly been pleased, as earnings have been mixed, while revenue figures have been rising. Relative to its peers and sector, Halliburton has been a year-to-date performance leader. Look for Halliburton to OUTPERFORM.

Wednesday, August 7, 2013

Why the S&P 500 Was Flat Last Week

Investors have done well this month. Despite the "sell in May and go away" cliche, those who have hung in there have seen the S&P 500 (SNPINDEX: ^GSPC  ) increase by more than 4% since the month began. This most recent week, in fact, was the only five-day period in which stocks declined.

By all appearances, you'd be excused for wondering why stocks didn't continue their upward climb. On Wednesday, the National Association of Realtors released data showing that existing-home sales increased last month by 9.7% on a year-over-year basis.

This upbeat assessment was confirmed on the same day by the quarterly earnings of Toll Brothers (NYSE: TOL  ) , the nation's largest luxury-home builder. The company's fiscal second-quarter results showed that its net signed contracts rose by an impressive 36% compared with the same three months in 2012.

And Thursday was the bearer of more good news. Early in the morning, the Labor Department noted that jobless claims in the previous week had fallen to 340,000, down from 363,000 the previous week. And on the same day, the Commerce Department said (link opens PDF) that new home sales edged up last month to the second highest level since the financial crisis.

So why again did the market go down?

The impetus for the market's stagnant performance lay at the feet of the Federal Reserve. On Wednesday, the chairman of the Fed, Ben Bernanke, testified before Congress about the possibility that the central bank could begin to taper back on its monthly bond purchases at one of its "next few meetings." He tempered this statement, however, be noting that monetary policymakers would do so only if there's evidence of "real and sustainable progress in the labor-market outlook."

Bernanke's testimony was subsequently seconded by the release of the minutes from the bank's most recent monetary policy committee meeting. Click here to read more about this.

In terms of individual stocks, the top-performing component on the S&P 500 last week was Hewlett-Packard (NYSE: HPQ  ) , which saw its shares rise by nearly 14% throughout the week. Most of the gain came on Thursday, a day after the personal-computer maker announced better-than-expected quarterly earnings. As my colleague Dan Dzombak discussed at the time, while HP missed estimates on the top line, its bottom-line beat was clearly enough to satisfy investors.

Top 5 Safest Stocks To Watch For 2014

Meanwhile, the worst-performing stock on the index was Dean Foods (NYSE: DF  ) , which lost more than half of its value. This otherwise disturbing performance followed the company's spinoff of its organic-foods division, WhiteWave Foods (NYSE: WWAV  ) . As fellow Fool Rich Duprey covered here, each Dean Foods shareholder received 0.25544448 shares of WhiteWave class A stock and 0.36380189 shares of its class B stock for every share of Dean Foods.

The Motley Fool's top stock for 2013
The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock it is in the brand-new free report: "The Motley Fool's Top Stock for 2013." Just click here to access the report and find out the name of this under-the-radar company.

Tuesday, August 6, 2013

How Will Judge Jackson Handle Google's Confirmed Workaround?‎

Google (GOOG) continues to fight back in its ongoing case against Vringo (VRNG) -- this time with big and important news. What news? A certified workaround to Vringo's patents. What was previously a rumor, is now a reality based on Google's newest representations.

Some background. Google and Vringo are in the midst of several battles relating to Vringo's assertion that Google is infringing on two patents that Vringo acquired from Lycos. There are at least three ongoing battles, all at various stages. The battle at the earliest stage is the Federal Circuit appeal that will be kicking off soon. That process should take somewhere between one and two and a half years once it gets going in earnest, and is the true battleground on the merits of Vringo's case. As we have previously written, if Google posts a bond for any damages awarded by the District Court, then Google will not be required to pay any royalties (verdict award or ongoing royalties) unless and until Vringo successfully preserves its infringement and validity rulings on appeal. In Google's brief last night, they expressly reserved the right to move for such a stay of royalty payments. (See footnote 18 on page 26 of the Google's brief: "Defendants reserve the right to seek a stay of any royalty payment pending appeal.")

Another current battleground is in the United States Patent and Trademark Office. Google has initiated re-examinations on the two patents that Vringo has asserted, and has already secured a final rejection of all of the asserted claims of the '420 patent. The re-examination documents can be found here. Vringo needs to appeal that decision to the BPAI, and ultimately the Federal Circuit will have the last word. The re-examination of the '664 patent is lagging a bit, but will likely follow the same pathway as the '420 patent. At the end of the process, these patents will either be valid or not over the prior art that Google has asserted. For now, Google has secured the PTO's agreement (a position th! at the PTO will have to defend in front of the Federal Circuit if the BPAI certifies the Final Rejection) that the '420 patent claims should never have issued in their current form, because of the prior art that Google has now brought to the PTO's attention for the first time. (The final rejection is also an important factor in the decision whether to enhance royalties for ongoing infringement.)

Finally, the most advanced battleground is the District Court case pending before Judge Jackson in the Eastern District of Virginia. That case is in its final stage, with one more motion for the Judge to decide -- Vringo's request for an ongoing royalty. Last night, Google revealed its opposition to Vringo's motion.

Having raised a number of arguments (some unlikely to succeed) in attempt to knock down or entirely eliminate the ongoing running royalties, one headline from Google's filing last night stood out. Google represented to the Court that it has implemented a workaround to Vringo's patents. This representation should not be viewed lightly. Google's attorneys have legal and ethical obligations to tell the truth to the Court, and they submitted sworn affidavit testimony that is punishable by a felony perjury count if untrue or unfounded. (See multiple Google declarations in support of their brief) Google claimed that the workaround is one that falls outside the scope of any of Vringo's infringement arguments. So according to Google, as of May 11, 2013 -- it no longer infringes the '420 and '664 patents even under Vringo's infringement theories. So if there is any ongoing royalty, it should be limited to a royalty base covering a very limited period of time. In prior filings, Google had hinted that they were implementing a workaround. In last night's filing, they confirmed that it is already in place.

Yet, even if Google's workaround is in place, the question remains whether it is still infringing Vringo's patents. It is axiomatic that Google will not need to pay any ongoing royalties to Vr! ingo if t! hey are no longer infringing. Judge Jackson now has to decide what he will do with Google's new sworn representations of a workaround. (To be clear, this is a separate question from whether or not the Judge will apply an enhanced royalty rate for ongoing royalties.) As we see it, he has two choices:

1) Judge Jackson can choose to postpone determining whether Google's workaround continues to infringe Vringo's patents until after the Federal Circuit's appeal runs its course. That means, he can assign a royalty rate for ongoing damages to apply to any post-judgment infringement, but stay his determination of whether the workaround is a non-infringing alternative until after the appeal is over. From his perspective, the appeal may upset the jury's finding of infringement or validity, rendering the issue of whether the workaround is infringing moot. Further, Vringo will not be able to claim much prejudice as result of such a stay because, as we previously discussed in an earlier article, Google is entitled to stay enforcement of any past or ongoing royalties provided it posts a bond. In short, the Judge can postpone his required evaluation of Google's workaround until the "bigger" issues are decided in a year or two in the Federal Circuit appeal or...

2) Judge Jackson can open limited discovery now on the workaround, and use it to help in his determination of the appropriate ongoing royalty rate. While that will not likely require a new trial, it will involve a lengthy process that could stretch out for months while he determines whether Google's workaround is more than minimally different from Google's prior product. (As an aside, the question of whether Google's workaround is a non-infringing alternative will not be addressed by the USPTO, but only by the District Court.)

While we wait for Vringo's reply, our initial take is that Judge Jackson is likelier to choose option 1, and push off an evaluation of Google's workaround on the merits until after the Federal Circuit decides w! hether or! not the jury verdict should stand. Such a delay would not prejudice Vringo, since they will not be getting royalty payments until then anyway. In light of this workaround, Vringo's best hope for good news is on the enhancement question before the Judge, but even they know that they are a long way from collection day.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. (More...)

Additional disclosure: We were long Vringo, but closed our position due to risks. Some members hedged against those risks by buying put options, which were closed as well.

Monday, August 5, 2013

3 Humongous Health-Care Stocks This Week

Few sectors see as many stocks gaining in the double-digits each week as health care. The past week proved to be no exception. Here are three of the most humongous health-care stocks over the last five days.

Good omen
Xoma Pharmaceuticals (NASDAQ: XOMA  ) reported first-quarter results on Wednesday. The company announced lower revenue compared with the same period last year, but the market didn't care. Shares surged nearly 19% on other news from Xoma.

The company said that encouraging interim results came in from a phase 2 study of gevokizumab in treating moderate to severe acne vulgaris. It also announced preliminary data from another phase 2 study of the drug in treating Behçet's uveitis conducted by its French partner, Servier.  

Results from the Servier study were enough to prompt financial-services firm Ladenburg Thalmann to increase its price target for Xoma from $5 to $6 per share. Ladenburg sees the phase 2 news as a good omen and thinks there could now be lower risk associated with an upcoming phase 3 trial for gevokizumab.

Surprise, surprise
A great year got even better for health-information provider WebMD (NASDAQ: WBMD  ) . The company reported first-quarter results this week that surprised the market with higher revenue and net income than were expected. Shares were up nearly 17% for the week.

WebMD announced a loss for the first quarter of $0.03 per share. That surprised analysts, who were expecting a $0.15-per-share loss. The figure also reflects considerable improvement over the $0.14-per-share loss from the same period in 2012.

The company's revenue for first quarter totaled $112.8 million. Analysts expected only $106.6 million in revenue.

Observers got one other surprise. WebMD announced the departure of its CEO, Cavan Redmond. David Schlanger, who previously served the company as senior vice president of strategic and corporate development, will replace Redmond on an interim basis.

Top line makes everything fine
Sequenom (NASDAQ: SQNM  ) lost more money in the first quarter than it did in the same period last year. The life-sciences company also missed the average analyst earnings estimate. Did shares fall? Nope -- they jumped 14%.

Strong top-line growth appears to be the catalyst for Sequenom. The company reported first-quarter revenue of $38.5 million, a whopping 158% year-over-year increase. Its diagnostic services revenue grew 38% from the fourth quarter of 2012.  

Sequenom's MaterniT21 Plus fetal test saw exceptionally strong results. CEO Harry F. Hixson Jr. said that 35,000 of these tests were accessioned during the first quarter, bringing the total volume since the product was launched in late 2011 to more than 100,000. Hixson also noted that company has made significant process in obtaining approval for reimbursement of MaterniT21 Plus.

Staying power
Which of this week's humongous performers is most likely to keep good news flowing for investors? All three potentially could continue rewarding shareholders.

Overall, though, I give the nod to WebMD. The company experienced a dismal 2012, but things are looking up. It has a strong brand and the CEO change is a good move in my view.

While you can certainly make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

Sunday, August 4, 2013

Would You Give a Ride to Apple's Biggest Mistakes?

For a company with a long history of hits, Apple (NASDAQ: AAPL  ) has two rather prominent tarnishes on its record in recent years: Siri and Maps. Siri has mostly not lived up to its full revolutionary potential and has been relegated to little more than a novelty feature. Apple's mapping missteps are also well documented, and Tim Cook has directly apologized over the service's shortfalls.

Would you give a ride to both Siri and Maps?

We need a lift
That's what Apple may be betting on in the next version of iOS, according to 9to5Mac's well-placed sources. The Mac maker is reportedly looking to "aggressively" push into car integration with the two services in iOS 7, which will be unveiled in June.

Apple is collaborating with numerous automakers to add center consoles that an iDevice could attach to, which would provide a redesigned Apple Maps in lieu of current proprietary GPS systems.

Recent events also lend to the idea that Apple wants more of a presence in automobiles. General Motors (NYSE: GM  ) has partnered with Apple to integrate Siri's Eyes Free feature in the Chevrolet Spark and Sonic. Volkswagen recently unveiled an iBeetle that integrates directly with iPhones after collaborating with Apple. Honda Motors (NYSE: HMC  ) is also adding Eyes Free to models in its 2013 lineup of Hondas and Acuras. Automakers benefit by adding a complementary selling feature that appeals to Apple's large installed base.

It's also worth noting that as part of Apple's executive shakeup late last year, Siri and Maps were both rolled under the jurisdiction of online services exec Eddy Cue. Scott Forstall took the blame for both fumbles, and Cue is known as a man who fixes things. Cue also happens to be a car enthusiast and joined Ferrari's board of directors late last year.

Both Siri and Maps are only going to get better before. Apple has little choice but to bolster Siri's capabilities, especially with Google (NASDAQ: GOOG  ) launching Now on iOS this week. Now has been praised as what Siri should have been, and bringing the rival virtual assistant to iOS will put some pressure on Apple to up Siri's game.

In fact, Now will reach more iOS users than it does Android users. Only 25% of Android devices use Jelly Bean, which includes Now, while Now will be available on all iDevices on iOS 5 or later, which includes all iPhones sold since 2009.

Apple's also been hiring mapping engineers to beef up its map making prowess. It may never catch up to Google's defining service, but there's still plenty of work needed to get Apple Maps competitive.

Top 10 Value Stocks To Buy For 2014

Siri and Maps may have been big mistakes thus far, but there are worse backseat drivers.

There's no doubt that Apple is at the center of technology's largest revolution ever and that longtime shareholders have been handsomely rewarded, with more than 1,000% gains. However, there is a debate raging as to whether Apple remains a buy. The Motley Fool's senior technology analyst and managing bureau chief, Eric Bleeker, is prepared to fill you in on reasons to buy and reasons to sell Apple and what opportunities are left for the company (and your portfolio) going forward. To get instant access to his latest thinking on Apple, simply click here now.

Saturday, August 3, 2013

5 Stocks Begging for a Short Squeeze

There's never a shortage of naysayers on Wall Street.

There are plenty of investors betting against publicly traded companies by selling them short, hoping to profit if the share prices head lower. However, some stocks have unusually large sums of short-sellers relative to their typical trading activity. This results in a high short interest ratio, and it's something that both bulls and bears need to watch closely.

The short interest ratio is easy enough to calculate. Take the total number of shares sold short, and divide that by the average number of shares in that stock that trade in a day. That's the short interest ratio, or the number of days that it would take to cover all of those bearish positions given typical trading volume.

There could be some legitimate reasons for high short interest ratios. A stock could have a lot of convertible debt out there and investors are merely hedging their equity risk. However, for the most part, a stock with a high short interest ratio is also a logical candidate for a short squeeze, sending the stock higher at the first whiff of a positive catalyst as the worrywarts scramble to close out their positions.

Let's take a look at a few companies with unusually high short interest ratios as of late last month.

Company 

Short Interest

Avg. Daily Volume

S.I.R.

5 Best Growth Stocks To Own Right Now

Higher One (NYSE: ONE  )

10.2 million

138,449

73

Exelixis (NASDAQ: EXEL  )

37.5 million

838,530

45

Capstone Turbine (NASDAQ: CPST  )

32.9 million

1,021,654

32

Fusion-io (NYSE: FIO  )

28.8 million

1,016,985

28

IMAX (NYSE: IMAX  )

14.2 million

512,971

28

Source: Barron's.

Feeding the bears
Higher One was a promising trailblazer a few years ago, offering colleges and their coeds a cost-efficient way to manage financial aid and refunds. There have been a few hiccups along the way, and now growth has slowed dramatically. The good news for Higher One is that it still watches over millions of accounts and its retention rate with campuses is holding up well. Adjusted revenue growth of 9% last year isn't too shabby.

Exelixis is hard at work tackling cancer. Shorts were left stinging last week when the stock soared 14% after delivering inspiring preclinical data detailing the effectiveness of its lead compound's ability to treat cancer tumors that have metastasized to the bone. However, the approval process is torturously long, and shorts are naturally betting that Exelixis won't pan out.

Capstone Turbine is making co-generation turbines that run on different fuel types. Capstone isn't profitable, but Wall Street's banking on breakeven results for its latest fiscal year that started this month. Capstone has had no problem getting potential customers to buy in, closing out its latest quarter with $136.5 million in orders. Last week it announced its first order for micro-turbine energy systems for China's oil and gas market.

Fusion-io has had a volatile trading history since going public two summers ago, and that's probably part of the appeal for short-sellers here. Its ioMemory platform provides a storage solution that speeds up virtualization, databases, cloud computing, big data, and performance applications. Growth was certainly there last time out. Revenue soared 43% in its latest fiscal quarter, and profitability more than doubled. However, Fusion-io's guidance called for a sharp sequential dip. We'll know how that plays out in next week's report.

Finally, we have IMAX. Critics have been arguing that the multiplex is dead, suggesting that IMAX's supersized theatrical experiences won't be enough to save the movie theater industry. Reality has gone with more of a Hollywood ending. IMAX continues expanding, and movie studios continue to embrace the fast-growing premium platform. Just yesterday, IMAX announced further expansion in Mexico and a deal to carry more Paramount Pictures releases.

Waiting is the hardest part
All five of these companies have their challenges, but it's easy to see how positive catalysts in upcoming quarterly results -- or upbeat events along the way -- could send the shorts scrambling for the exits, driving the shares higher in a short squeeze.

Shorting these five companies doesn't seem like a bright idea, but it would be a boring marketplace if everyone were bullish.

Are you part of the 99%? The Motley Fool's new free report highlights three less-than-luxurious stocks the 1% may be overlooking. Just click here to read it now.

Best Tiny Stocks For 2019

Best Tiny Stocks For 2019